Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JR.1.1.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
JR.1.1.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JD.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JD.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
JD.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JG.3.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JG.3.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
JG.3.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KE.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KE.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
KE.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HV.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HV.1.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HV.1.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.2.86.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.86.5NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
BA.2.86.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HK.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.8NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HK.8NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HK.26.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.26.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HK.26.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XCPECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCPNCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
XCPNUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FL.1.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.1.8NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
FL.1.8NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
EG.6.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.6.1.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
EG.6.1.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
EG.5.1.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.12NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
EG.5.1.12NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JF.1.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JF.1.1.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
JF.1.1.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HK.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.11NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HK.11NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JN.3.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.3.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19646.7China
JN.3.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XDEECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDENCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
XDENUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KE.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KE.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
KE.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used